Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes.
Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes. Diabetes Obes Metab. 2017 05; 19(5):613-614.